374 related articles for article (PubMed ID: 25278683)
21. Effects of selective COX-2 inhibitor and Helicobacter pylori eradication on precancerous gastric lesions.
Wong BC; Zhang L; Ma JL; Pan KF; Li JY; Shen L; Liu WD; Feng GS; Zhang XD; Li J; Lu AP; Xia HH; Lam S; You WC
Gut; 2012 Jun; 61(6):812-8. PubMed ID: 21917649
[TBL] [Abstract][Full Text] [Related]
22. Correlations among Helicobacter pylori infection and the expression of cyclooxygenase-2 and vascular endothelial growth factor in gastric mucosa with intestinal metaplasia or dysplasia.
Liu D; He Q; Liu C
J Gastroenterol Hepatol; 2010 Apr; 25(4):795-9. PubMed ID: 20492336
[TBL] [Abstract][Full Text] [Related]
23. NF-κB/miR-18a-3p and miR-4286/BZRAP1 axis may mediate carcinogenesis in Helicobacter pylori-Associated gastric cancer.
Tsai CC; Chen TY; Tsai KJ; Lin MW; Hsu CY; Wu DC; Tsai EM; Hsieh TH
Biomed Pharmacother; 2020 Dec; 132():110869. PubMed ID: 33113427
[TBL] [Abstract][Full Text] [Related]
24. Multicentric randomised study of
Leja M; Park JY; Murillo R; Liepniece-Karele I; Isajevs S; Kikuste I; Rudzite D; Krike P; Parshutin S; Polaka I; Kirsners A; Santare D; Folkmanis V; Daugule I; Plummer M; Herrero R
BMJ Open; 2017 Aug; 7(8):e016999. PubMed ID: 28801429
[TBL] [Abstract][Full Text] [Related]
25. Helicobacter pylori potentiates epithelial:mesenchymal transition in gastric cancer: links to soluble HB-EGF, gastrin and matrix metalloproteinase-7.
Yin Y; Grabowska AM; Clarke PA; Whelband E; Robinson K; Argent RH; Tobias A; Kumari R; Atherton JC; Watson SA
Gut; 2010 Aug; 59(8):1037-45. PubMed ID: 20584780
[TBL] [Abstract][Full Text] [Related]
26. Helicobacter pylori associated gastric intestinal metaplasia: Treatment and surveillance.
Liu KS; Wong IO; Leung WK
World J Gastroenterol; 2016 Jan; 22(3):1311-20. PubMed ID: 26811668
[TBL] [Abstract][Full Text] [Related]
27. Helicobacter pylori eradication to prevent gastric cancer: underlying molecular and cellular mechanisms.
Tsuji S; Tsujii M; Murata H; Nishida T; Komori M; Yasumaru M; Ishii S; Sasayama Y; Kawano S; Hayashi N
World J Gastroenterol; 2006 Mar; 12(11):1671-80. PubMed ID: 16586533
[TBL] [Abstract][Full Text] [Related]
28. Promoter methylation regulates Helicobacter pylori-stimulated cyclooxygenase-2 expression in gastric epithelial cells.
Akhtar M; Cheng Y; Magno RM; Ashktorab H; Smoot DT; Meltzer SJ; Wilson KT
Cancer Res; 2001 Mar; 61(6):2399-403. PubMed ID: 11289104
[TBL] [Abstract][Full Text] [Related]
29. Artemisinin and its derivatives prevent Helicobacter pylori-induced gastric carcinogenesis via inhibition of NF-κB signaling.
Su T; Li F; Guan J; Liu L; Huang P; Wang Y; Qi X; Liu Z; Lu L; Wang D
Phytomedicine; 2019 Oct; 63():152968. PubMed ID: 31280140
[TBL] [Abstract][Full Text] [Related]
30. Helicobacter pylori infection, oncogenic pathways and epigenetic mechanisms in gastric carcinogenesis.
Ding SZ; Goldberg JB; Hatakeyama M
Future Oncol; 2010 May; 6(5):851-62. PubMed ID: 20465395
[TBL] [Abstract][Full Text] [Related]
31. The novel ZEB1-upregulated protein PRTG induced by Helicobacter pylori infection promotes gastric carcinogenesis through the cGMP/PKG signaling pathway.
Xiang T; Yuan C; Guo X; Wang H; Cai Q; Xiang Y; Luo W; Liu G
Cell Death Dis; 2021 Feb; 12(2):150. PubMed ID: 33542225
[TBL] [Abstract][Full Text] [Related]
32. DNA methylation accumulation in gastric mucosa adjacent to cancer after Helicobacter pylori eradication.
Tahara S; Tahara T; Horiguchi N; Kato T; Shinkai Y; Yamashita H; Yamada H; Kawamura T; Terada T; Okubo M; Nagasaka M; Nakagawa Y; Shibata T; Yamada S; Urano M; Tsukamoto T; Kurahashi H; Kuroda M; Ohmiya N
Int J Cancer; 2019 Jan; 144(1):80-88. PubMed ID: 29978464
[TBL] [Abstract][Full Text] [Related]
33. Anti-Helicobacter pylori therapy followed by celecoxib on progression of gastric precancerous lesions.
Zhang LJ; Wang SY; Huo XH; Zhu ZL; Chu JK; Ma JC; Cui DS; Gu P; Zhao ZR; Wang MW; Yu J
World J Gastroenterol; 2009 Jun; 15(22):2731-8. PubMed ID: 19522023
[TBL] [Abstract][Full Text] [Related]
34. Roles of cyclooxygenase-2 and microsomal prostaglandin E synthase-1 expression and beta-catenin activation in gastric carcinogenesis in N-methyl-N-nitrosourea-treated K19-C2mE transgenic mice.
Takasu S; Tsukamoto T; Cao XY; Toyoda T; Hirata A; Ban H; Yamamoto M; Sakai H; Yanai T; Masegi T; Oshima M; Tatematsu M
Cancer Sci; 2008 Dec; 99(12):2356-64. PubMed ID: 19018769
[TBL] [Abstract][Full Text] [Related]
35. Molecular Pathogenesis of Helicobacter pylori-Related Gastric Cancer.
Shimizu T; Marusawa H; Watanabe N; Chiba T
Gastroenterol Clin North Am; 2015 Sep; 44(3):625-38. PubMed ID: 26314672
[TBL] [Abstract][Full Text] [Related]
36. Treatment of Helicobacter pylori and prevention of gastric cancer.
Cheung TK; Wong BC
J Dig Dis; 2008 Feb; 9(1):8-13. PubMed ID: 18251788
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of gastric carcinogenesis by the hormone gastrin is mediated by suppression of TFF1 epigenetic silencing.
Tomita H; Takaishi S; Menheniott TR; Yang X; Shibata W; Jin G; Betz KS; Kawakami K; Minamoto T; Tomasetto C; Rio MC; Lerkowit N; Varro A; Giraud AS; Wang TC
Gastroenterology; 2011 Mar; 140(3):879-91. PubMed ID: 21111741
[TBL] [Abstract][Full Text] [Related]
38. Gastric Carcinogenesis and Underlying Molecular Mechanisms: Helicobacter pylori and Novel Targeted Therapy.
Nishizawa T; Suzuki H
Biomed Res Int; 2015; 2015():794378. PubMed ID: 25945346
[TBL] [Abstract][Full Text] [Related]
39. Relationship between VacA Toxin and Host Cell Autophagy in Helicobacter pylori Infection of the Human Stomach: A Few Answers, Many Questions.
Ricci V
Toxins (Basel); 2016 Jul; 8(7):. PubMed ID: 27376331
[TBL] [Abstract][Full Text] [Related]
40. The role of microRNAs in Helicobacter pylori pathogenesis and gastric carcinogenesis.
Noto JM; Peek RM
Front Cell Infect Microbiol; 2011; 1():21. PubMed ID: 22919587
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
